IMPACT OF ADENOTONSILLECTOMY ON PHARMACOTHERAPY IN CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER AND ADENOTONSILLAR HYPERTROPHY

被引：0

作者：

Huon, L. -K. ^{[1
]}

Liu, S. Y. ^{[2
]}

机构：

[1] Cathay Gen Hosp, Taipei, Taiwan

[2] Stanford Univ, Sch Med, Stanford, CA 94305 USA

来源：

SLEEP MEDICINE | 2017年 / 40卷

关键词：

D O I：

10.1016/j.sleep.2017.11.409

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：E140 / E140

页数：1

共 50 条

[21] Advances in the pharmacotherapy of attention-deficit/hyperactivity disorder
Kollins, Scott H.
March, John S.
BIOLOGICAL PSYCHIATRY, 2007, 62 (09) : 951 - 953
[22] ATTENTION-DEFICIT/HYPERACTIVITY DISORDER: FOCUS ON PHARMACOTHERAPY
Wilens, Timothy E.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2016, 55 (10): : S99 - S99
[23] Pharmacotherapy and Academic Achievement Among Children with Attention-Deficit/Hyperactivity Disorder
Barnard-Brak, Lucy
Brak, Victor
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2011, 21 (06) : 597 - 603
[24] Emotional Lability in Patients with Attention-Deficit/Hyperactivity Disorder: Impact of Pharmacotherapy
Childress, Ann C.
Sallee, Floyd R.
CNS DRUGS, 2015, 29 (08) : 683 - 693
[25] Impact of adenotonsillectomy on ADHD and nocturnal enuresis in children with chronic adenotonsillar hypertrophy
Somuk, Battal Tahsin
Bozkurt, Hasan
Goktas, Goksel
Demir, Osman
Gurbuzler, Levent
Eyibilen, Ahmet
AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2016, 37 (01) : 27 - 30
[26] Emotional Lability in Patients with Attention-Deficit/Hyperactivity Disorder: Impact of Pharmacotherapy
Ann C. Childress
Floyd R. Sallee
CNS Drugs, 2015, 29 : 683 - 693
[27] Perfectionism and attention deficit hyperactivity disorder among parents of children with attention deficit hyperactivity disorder
Doksat, Neslim Guvendeger
Zengin, Hande Balkanli
Doksat, Mehmet Kerem
CUKUROVA MEDICAL JOURNAL, 2018, 43 (03): : 581 - 588
[28] Efficacy and Safety Limitations of Attention-Deficit Hyperactivity Disorder Pharmacotherapy in Children and Adults
Wigal, Sharon B.
CNS DRUGS, 2009, 23 : 21 - 31
[29] Efficacy and Safety Limitations of Attention-Deficit Hyperactivity Disorder Pharmacotherapy in Children and Adults
Sharon B. Wigal
CNS Drugs, 2009, 23 : 21 - 31
[30] Variations in pharmacotherapy for attention deficit hyperactivity disorder in managed care
Boles, M
Lynch, FL
DeBar, LL
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2001, 11 (01) : 43 - 52

← 1 2 3 4 5 →